1 – 139 of 139
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clinical Implications of Discrepancy between One-stage Clotting and Chromogenic Factor IX Activity in Haemophilia B
(
- Contribution to journal › Article
-
Mark
Proteomic characterization of plasma in Lemierre's syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A : The LEOPOLD Kids Trial
(
- Contribution to journal › Article
- 2022
-
Mark
New Inhibitors in the Ageing Population : A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
(
- Contribution to journal › Article
-
Mark
Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Thrombotic Risk Determined by Protein C Receptor (PROCR) Variants among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article
- 2021
-
Mark
Reactome Pathway Analysis of Venous Thromboembolism, Peripheral Artery Disease, Stroke, and Coronary Artery Disease
(
- Contribution to journal › Letter
- 2020
-
Mark
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction : Rationale and Methodology
(
- Contribution to journal › Letter
-
Mark
Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis
(
- Contribution to journal › Article
- 2019
-
Mark
The Ultimate Murine Model of Immune Thrombocytopaenia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index
(
- Contribution to journal › Article
-
Mark
Next-Generation Sequencing of 17 Genes Associated with Venous Thromboembolism Reveals a Deficit of Non-Synonymous Variants in Procoagulant Genes
(
- Contribution to journal › Article
-
Mark
Platelet Indices and Risk of Death and Cardiovascular Events : Results from a Large Population-Based Cohort Study
(
- Contribution to journal › Article
- 2018
-
Mark
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
(
- Contribution to journal › Article
-
Mark
Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients
(
- Contribution to journal › Article
- 2017
-
Mark
Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR
(
- Contribution to journal › Article
-
Mark
Paracelsus, poison, and colistin
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans
(
- Contribution to journal › Article
-
Mark
The importance of genetic factors for the development of arthropathy : A longitudinal study of children and adolescents with haemophilia A
(
- Contribution to journal › Article
-
Mark
Extracellular nucleic acids in immunity and cardiovascular responses : Between alert and disease
(
- Contribution to journal › Scientific review
-
Mark
Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors
(
- Contribution to journal › Article
- 2016
-
Mark
Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.
(
- Contribution to journal › Scientific review
-
Mark
Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis
(
- Contribution to journal › Article
-
Mark
BRCA2 gene mutations and coagulation-associated biomarkers
(
- Contribution to journal › Article
-
Mark
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors
(
- Contribution to journal › Article
- 2015
-
Mark
Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.
(
- Contribution to journal › Article
-
Mark
Genetic aspects of thrombotic disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
(
- Contribution to journal › Article
-
Mark
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of well managed warfarin: A report from the Swedish quality register Auricula
(
- Contribution to journal › Article
-
Mark
Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.
(
- Contribution to journal › Article
-
Mark
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions
(
- Contribution to journal › Scientific review
-
Mark
Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Family history of venous thromboembolism as a risk factor and genetic research tool.
(
- Contribution to journal › Article
-
Mark
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10
(
- Contribution to journal › Article
-
Mark
Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI : an observational comparative study
(
- Contribution to journal › Article
- 2014
-
Mark
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
(
- Contribution to journal › Article
-
Mark
Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Targeted mass spectrometry analysis of neutrophil-derived proteins released during sepsis progression.
(
- Contribution to journal › Article
-
Mark
The coagulation system and its function in early immune defense.
(
- Contribution to journal › Article
-
Mark
Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories
(
- Contribution to journal › Article
- 2013
-
Mark
Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
(
- Contribution to journal › Article
-
Mark
Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
Age-and sex-specific seasonal variation of venous thromboembolism in patients with and without family history: a nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
Old genes and new genes: The evolution of the kallikrein locus.
(
- Contribution to journal › Scientific review
-
Mark
Antimicrobial activity of fibrinogen and fibrinogen-derived peptides - a novel link between coagulation and innate immunity.
(
- Contribution to journal › Article
-
Mark
Anti-inflammatory, anti-coagulant, anti-biotic?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation
(
- Contribution to journal › Article
-
Mark
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?
(
- Contribution to journal › Scientific review
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor
(
- Contribution to journal › Article
-
Mark
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.
(
- Contribution to journal › Article
-
Mark
Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems
(
- Contribution to journal › Article
- 2011
-
Mark
Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B
(
- Contribution to journal › Article
-
Mark
Determination of age-specific and sex-specific familial risks for the different manifestations of venous thromboembolism: A nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
A large deletion identified in a Swedish family with type 1 VWD
(
- Contribution to journal › Letter
-
Mark
Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article
- 2010
-
Mark
Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
(
- Contribution to journal › Article
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
- 2009
-
Mark
The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor
(
- Contribution to journal › Article
-
Mark
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia
(
- Contribution to journal › Letter
-
Mark
Platelets interact with bacterial pathogens.
(
- Contribution to journal › Article
- 2008
-
Mark
Surgical evaluation of a recombinant factorVIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients
(
- Contribution to journal › Article
-
Mark
Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes
(
- Contribution to journal › Article
-
Mark
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease
(
- Contribution to journal › Article
-
Mark
FactorVIIa and its potential therapeutic use in bleeding-associated pathologies
(
- Contribution to journal › Article
-
Mark
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
(
- Contribution to journal › Article
-
Mark
Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
(
- Contribution to journal › Article
-
Mark
High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)
(
- Contribution to journal › Article
-
Mark
Plasma-derived biological medicines used to promote haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Platelets play a direct role in sepsis-associated endothelial cell death
(
- Contribution to journal › Debate/Note/Editorial
- 2007
-
Mark
The tale of protein S and C4b-binding protein, a story of affection
(
- Contribution to journal › Article
-
Mark
Coagulation factorV and thrombophilia: Background and mechanisms
(
- Contribution to journal › Article
-
Mark
Low soluble thrombomodulin activity and antigen is associated with a family history of heart disease while a high level is associated with a personal history of heart disease in type 2 diabetes
(
- Contribution to journal › Letter
-
Mark
The dual role of the contact system in bacterial infectious disease
(
- Contribution to journal › Article
-
Mark
Haemostasis, vascular biology, and infectious agents.
(
- Contribution to journal › Letter
-
Mark
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo
(
- Contribution to journal › Article
- 2006
-
Mark
Trousseau's syndrome - what is the evidence? A population-based autopsy study
(
- Contribution to journal › Article
-
Mark
Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.
(
- Contribution to journal › Article
-
Mark
A common origin of the 4143insA ADAMTS13 mutation
(
- Contribution to journal › Article
-
Mark
Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency
(
- Contribution to journal › Article
- 2005
-
Mark
Rebuttal: Meta-analysis of the relationship of factor V Leiden and intrauterine growth restriction - based on solid evidence?
(
- Contribution to journal › Letter
-
Mark
Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
(
- Contribution to journal › Article
-
Mark
Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Value of ventilation/perfusion SPECT detecting extensive pulmonary embolism in a patient with pneumonia.
(
- Contribution to journal › Article
- 2004
-
Mark
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
(
- Contribution to journal › Article
-
Mark
Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa.
(
- Contribution to journal › Article
-
Mark
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
(
- Contribution to journal › Article
- 2003
-
Mark
Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients
(
- Contribution to journal › Article
-
Mark
Stabilyte (TM) tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor
(
- Contribution to journal › Letter
-
Mark
Diabetes duration may modify the association between genetic variation in the glycoprotein la subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis
(
- Contribution to journal › Article
-
Mark
Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S.
(
- Contribution to journal › Article
-
Mark
Platelets give us many messages
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
Rapid intracellular degradation of a truncated mutant protein S (Q522X)
(
- Contribution to journal › Letter
-
Mark
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
(
- Contribution to journal › Article
-
Mark
Platelets: a new target for gene therapy of haemophilia B.
(
- Contribution to journal › Letter
-
Mark
Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S
(
- Contribution to journal › Article
-
Mark
Genetic and phenotypic variability between families with hereditary protein S deficiency
(
- Contribution to journal › Article
- 2001
-
Mark
Analytical considerations for free protein S assays in protein S deficiency
(
- Contribution to journal › Article
-
Mark
Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis
(
- Contribution to journal › Article
-
Mark
No increased risk of venous thrombosis in women taking tranexamic acid
(
- Contribution to journal › Letter
-
Mark
A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor
(
- Contribution to journal › Article
-
Mark
Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden--an evolutionary advantage?
(
- Contribution to journal › Letter
-
Mark
Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man
(
- Contribution to journal › Article
-
Mark
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism : Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls
(
- Contribution to journal › Article
- 2000
-
Mark
Impact, diagnosis and treatment of von Willebrand disease
(
- Contribution to journal › Article
- 1999
-
Mark
Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents
(
- Contribution to journal › Article
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Prophylactic infusion regimens in the management of hemophilia
(
- Contribution to journal › Article
-
Mark
The Ala25-Thr mutation in the thrombomodulin gene is not frequent in Swedish patients suffering from ischemic heart disease [9]
(
- Contribution to journal › Letter
-
Mark
Control of smooth muscle cell proliferation - The role of the basement membrane
(
- Contribution to journal › Article
- 1998
-
Mark
A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
(
- Contribution to journal › Article
-
Mark
A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen
(
- Contribution to journal › Article
-
Mark
Geographic distribution of the 20210 G to A prothrombin variant
(
- Contribution to journal › Article
- 1997
-
Mark
A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis
(
- Contribution to journal › Article
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article
-
Mark
A common thrombomodulin amino acid dimorphism is associated with myocardial infarction
(
- Contribution to journal › Article
-
Mark
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
-
Mark
Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface
(
- Contribution to journal › Article
- 1996
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
-
Mark
Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin
(
- Contribution to journal › Article
- 1995
-
Mark
Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease
(
- Contribution to journal › Article
- 1994
-
Mark
Study of the interaction of dextran and enoxaparin on haemostasis in humans
(
- Contribution to journal › Article
-
Mark
Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits
(
- Contribution to journal › Article
-
Mark
High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]
(
- Contribution to journal › Letter
-
Mark
Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis : A comparison with low molecular weight heparin
(
- Contribution to journal › Article
- 1992
-
Mark
Haplotype analysis of identical factor IX mutants using PCR
(
- Contribution to journal › Article
- 1990
-
Mark
Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats
(
- Contribution to journal › Article
- 1987
-
Mark
Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers
(
- Contribution to journal › Article
- 1986
-
Mark
Heparin-induced osteoporosis in rats
(
- Contribution to journal › Article
- 1983
-
Mark
Platelet adhesion in polytetrafluoroethylene (PTFE) vascular grafts in vivo and the influence of increased intramuscular pressure - An experimental model.
(
- Contribution to journal › Article